Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma Market Cap : 1.110B for Feb. 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 198.65B |
| Johnson & Johnson | 587.19B |
| Eli Lilly & Co. | 937.33B |
| Nektar Therapeutics | 1.241B |
| Rigel Pharmaceuticals, Inc. | 628.22M |
Market Cap Related Metrics
| PS Ratio | 74.12 |
| PEG Ratio | -0.1539 |
| Price to Book Value | 5.650 |
| Price | 26.53 |
| Earnings Yield | -17.08% |
| PEGY Ratio | -0.1539 |